Literature DB >> 9004369

Social scientists and the new tuberculosis.

P Farmer1.   

Abstract

In much of the world, tuberculosis (TB) remains the leading killer of young adults, in spite of the fact that effective chemotherapy has existed for 50 years. The epidemiology of TB, with its persistence in poor countries and resurgence among the poor of many industrialized nations, causes consternation among those charged with protecting the public's health. Two factors, ostensibly biological in nature, are commonly cited to explain this setback: the advent of HIV and the emergence of TB strains resistant to multiple drugs (MDR TB). But the strikingly patterned occurrence of MDR TB-in the United States afflicting those in homeless shelters and in the inner city, for example-speaks to some of the large-scale social forces at work in the new epidemic, which began before the advent of HIV. These forces (which include poverty, economic inequality, political violence, and racism) are examined through the experience of a young Haitian man with MDR TB, a disease never before described in Haiti. Insights from this case, and from other research on TB and HIV disease, are considered in the light of past anthropological writings on TB. It is argued that, often, social scientists mar contributions to an understanding of TB by making "immodest claims of causality" regarding its distribution and course. Alternative strategies for future sociomedical research on MDR TB are proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9004369     DOI: 10.1016/s0277-9536(96)00143-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  35 in total

1.  Anthropology of microbes.

Authors:  Amber Benezra; Joseph DeStefano; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-28       Impact factor: 11.205

2.  Structural forces and the production of TB-related stigma among Haitians in two contexts.

Authors:  Jeannine Coreil; Gladys Mayard; Kelly M Simpson; Michael Lauzardo; Yiliang Zhu; Mitchell Weiss
Journal:  Soc Sci Med       Date:  2010-08-05       Impact factor: 4.634

3.  Social constraints to TB/HIV healthcare: accounts from coinfected patients in South Africa.

Authors:  Amrita Daftary; Nesri Padayatchi
Journal:  AIDS Care       Date:  2012-04-24

4.  Structural violence in long-term, residential care for older people: comparing Canada and Scandinavia.

Authors:  Albert Banerjee; Tamara Daly; Pat Armstrong; Marta Szebehely; Hugh Armstrong; Stirling Lafrance
Journal:  Soc Sci Med       Date:  2011-12-07       Impact factor: 4.634

Review 5.  "One people, one blood": public health, political violence, and HIV in an Ethiopian-Israeli setting.

Authors:  D Seeman
Journal:  Cult Med Psychiatry       Date:  1999-06

6.  Nihilism and pragmatism in tuberculosis control.

Authors:  P Farmer; E Nardell
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

7.  Predictive power of air travel and socio-economic data for early pandemic spread.

Authors:  Parviez Hosseini; Susanne H Sokolow; Kurt J Vandegrift; A Marm Kilpatrick; Peter Daszak
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

Review 8.  Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations.

Authors:  Omar Galárraga; Becky L Genberg; Rosemarie A Martin; M Barton Laws; Ira B Wilson
Journal:  AIDS Behav       Date:  2013-09

9.  Exploring workplace TB interventions with foreign-born Latino workers.

Authors:  Donald E Eggerth; Brenna M Keller; Michael A Flynn
Journal:  Am J Ind Med       Date:  2018-05-15       Impact factor: 2.214

10.  "I can't do this, it's too much": building social inclusion in cancer diagnosis and treatment experiences of Aboriginal people, their carers and health workers.

Authors:  Carla Treloar; Rebecca Gray; Loren Brener; Clair Jackson; Veronica Saunders; Priscilla Johnson; Magdalena Harris; Phyllis Butow; Christy Newman
Journal:  Int J Public Health       Date:  2013-04-21       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.